All news on the topic: AstraZeneca

More than 40 per cent of jurists at the Court of Justice have declared private financial interests, with some working on cases concerning industries where they hold stakes.

Britain has finalized a U.S.-UK pharmaceutical trade deal, granting tariff-free access for UK-made medicines to the United States in exchange for paying higher prices for new U.S. medicines.

Pharmaceutical giant AstraZeneca has announced plans to revamp its US listing, while emphasizing that it will keep its headquarters in the UK and remain listed on the London market.

US President Donald Trump has announced a new set of tariffs, including a 100% levy on imported branded or patented drugs starting 1 October unless the company is establishing a factory in the US.

The chief executive of the pharmaceutical company Eli Lilly has remarked that the UK is “probably the worst country in Europe” when it comes to drug prices, amidst a conflict between the industry and government.